Published in Public Health Rep on March 03, 2014
Graying of the HIV epidemic: a challenge for inpatient medicine providers. J Community Hosp Intern Med Perspect (2015) 0.82
Gender-Related Risk Factors Improve Mortality Predictive Ability of VACS Index Among HIV-Infected Women. J Acquir Immune Defic Syndr (2015) 0.81
Hospitalizations among HIV controllers and persons with medically controlled HIV in the U.S. Military HIV Natural History Study. J Int AIDS Soc (2016) 0.81
Half of 30-Day Hospital Readmissions Among HIV-Infected Patients Are Potentially Preventable. AIDS Patient Care STDS (2015) 0.75
Emergency department use by people with HIV in Ontario: a population-based cohort study. CMAJ Open (2016) 0.75
Trends in hospital deaths among human immunodeficiency virus-infected patients during the antiretroviral therapy era, 1995 to 2011. J Hosp Med (2015) 0.75
Prevalence and hospital discharge status of human immunodeficiency virus-associated pulmonary arterial hypertension in the United States. Pulm Circ (2015) 0.75
Frailty in HIV: Epidemiology, Biology, Measurement, Interventions, and Research Needs. Curr HIV/AIDS Rep (2016) 0.75
Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines. AIDS Res Ther (2017) 0.75
Hospital days attributable to immune reconstitution inflammatory syndrome in persons living with HIV before and after the 2012 DHHS HIV guidelines. AIDS Res Ther (2017) 0.75
Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep (2009) 11.30
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA (1999) 10.93
The lifetime cost of current human immunodeficiency virus care in the United States. Med Care (2006) 5.87
Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr (2005) 3.92
The healthcare cost and utilization project: an overview. Eff Clin Pract (2002) 3.49
Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization. J Acquir Immune Defic Syndr (2000) 2.60
Racial disparities in HIV virologic failure: do missed visits matter? J Acquir Immune Defic Syndr (2009) 2.58
Failure to establish HIV care: characterizing the "no show" phenomenon. Clin Infect Dis (2007) 2.37
Risk factors for delayed initiation of medical care after diagnosis of human immunodeficiency virus. Arch Intern Med (2008) 2.31
Establishment, retention, and loss to follow-up in outpatient HIV care. J Acquir Immune Defic Syndr (2012) 2.19
Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data. Am J Public Health (2003) 2.16
Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature. Public Health Rep (2002) 2.14
The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women. J Acquir Immune Defic Syndr (2005) 1.96
Continuity of HIV-related medical care, New York City, 2005-2009: Do patients who initiate care stay in care? AIDS Patient Care STDS (2011) 1.87
Differences in access to zidovudine (AZT) among symptomatic HIV-infected persons. J Gen Intern Med (1991) 1.80
Are there gender differences in starting protease inhibitors, HAART, and disease progression despite equal access to care? J Acquir Immune Defic Syndr (2000) 1.67
Predictors of retention in HIV care among a national cohort of US veterans. HIV Clin Trials (2009) 1.65
Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states. J Acquir Immune Defic Syndr (2005) 1.64
Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005. AIDS (2008) 1.63
Race/ethnicity and risk of AIDS and death among HIV-infected patients with access to care. J Gen Intern Med (2009) 1.63
Patterns of engagement in care by HIV-infected adults: South Carolina, 2004-2006. AIDS (2009) 1.62
Effectiveness of highly-active antiretroviral therapy by race/ethnicity. AIDS (2006) 1.55
Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use? J Acquir Immune Defic Syndr (2010) 1.46
The diffusion of innovation in AIDS treatment: zidovudine use in two New Jersey cohorts. Health Serv Res (1995) 1.45
Inpatient health services utilization among HIV-infected adult patients in care 2002-2007. J Acquir Immune Defic Syndr (2010) 1.39
Hospital charges for people with AIDS in Washington State: utilization of a statewide hospital discharge data base. Am J Public Health (1988) 1.37
Disparities in receipt of antiretroviral therapy among HIV-infected adults (2002-2008). Med Care (2012) 1.28
Estimation of unmet need for HIV primary medical care: a framework and three case studies. AIDS Educ Prev (2005) 1.27
Techniques for handling missing data in secondary analyses of large surveys. Acad Pediatr (2010) 1.26
The changing pattern of admissions to a London hospital of patients with HIV: 1988-1997. Royal Free Centre for HIV Medicine. AIDS (1999) 1.26
Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 1.24
Disparities in outcomes for African American and Latino subjects in the Flexible Initial Retrovirus Suppressive Therapies (FIRST) trial. AIDS Patient Care STDS (2010) 1.23
Assessing HIV care and unmet need: eight data bases and a bit of perseverance. AIDS Care (2008) 1.12
Impact of antiretroviral therapy on decreasing hospitalization rates of HIV-infected patients in 2001. AIDS Res Hum Retroviruses (2002) 1.09
HIV infection in hospitalized patients and Medicaid enrollees: the accuracy of medical record coding. Am J Public Health (1993) 1.08
Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study. HIV Med (2004) 1.07
Gender differences in quality of HIV care in Ryan White CARE Act-funded clinics. Womens Health Issues (2006) 1.05
Black race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study. BMC Infect Dis (2009) 0.93
Patterns of hospital use by patients with diagnoses related to HIV infection. Public Health Rep (1993) 0.87
A longitudinal analysis of hospitalization and emergency department use among human immunodeficiency virus-infected women reporting protease inhibitor use. Clin Infect Dis (2001) 0.86